GSK

GSK | NYSE

Price Alert Chart Builder DCF Calculator

$50.69

-$0.39 (-0.76%)

Sep 22, 2026, 1:34 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	8.45B	7.63B	8.62B	8.55B	7.99B	7.52B	8.12B	8.01B	7.88B	7.36B	8.05B	8.15B	7.18B	6.95B	7.38B	7.83B	6.93B	7.19B	9.53B	6.63B	5.84B	7.42B
Cost of Revenue	2.11B	1.88B	2.66B	2.26B	2.17B	1.94B	2.56B	2.4B	2.12B	1.97B	2.42B	2.27B	1.93B	1.94B	2.24B	2.42B	2.18B	2.72B	3.68B	2.02B	1.71B	2.48B
Gross Profit	6.34B	5.75B	5.96B	6.29B	5.82B	5.58B	5.56B	5.62B	5.76B	5.39B	5.63B	5.88B	5.25B	5.01B	5.14B	5.41B	4.75B	4.47B	5.85B	4.61B	4.13B	4.94B
Operating Income	2.41B	2.29B	1.51B	2.59B	2.02B	2.22B	696M	189M	1.65B	1.49B	573M	1.95B	2.14B	2.08B	1.87B	1.19B	1.08B	2.29B	895M	1.38B	1.28B	1.69B
Interest Income	58.3M	22M	n/a	26M	50M	54M	-51M	32M	24M	32M	35.98M	24M	33M	29M	24.86M	22M	21M	7M	999.05K	4M	7M	10M
Pretax Income	355.84M	2.14B	950M	2.46B	1.89B	2.11B	563M	64M	1.5B	1.36B	379M	1.79B	1.99B	1.91B	1.63B	1.01B	896M	2.09B	706M	1.19B	1.07B	1.52B
Net Income	437.26M	1.74B	636M	2.01B	1.44B	1.62B	414M	-58M	1.17B	1.05B	350M	1.46B	1.62B	1.49B	1.46B	10.82B	838M	1.8B	749M	1.37B	1.4B	1.07B
Selling & General & Admin	2.2B	2.12B	2.64B	2.24B	2.14B	2.07B	2.66B	3.8B	2.47B	2.09B	2.68B	2.3B	2.27B	2.14B	2.44B	2.06B	2.07B	1.81B	3.26B	1.68B	1.69B	2.43B
Research & Development	1.73B	1.69B	2.35B	1.69B	2.02B	1.46B	2.03B	1.46B	1.48B	1.43B	2.05B	1.58B	1.34B	1.26B	1.8B	1.35B	1.24B	1.1B	1.45B	1.42B	1.17B	1.12B
Other Expenses	n/a	-350M	-534M	-232M	-366M	-169M	168M	167M	174M	382M	336M	55M	-504M	-477M	-965M	813M	364M	-735M	244M	136M	-1M	-300M
Operating Expenses	3.93B	3.46B	4.46B	3.7B	3.8B	3.36B	4.86B	5.43B	4.12B	3.9B	5.06B	3.93B	3.11B	2.93B	3.27B	4.22B	3.67B	2.18B	4.95B	3.23B	2.86B	3.25B
Interest Expense	182.95M	167M	174M	167M	184M	162M	144M	156M	174M	166M	275.41M	182M	185M	203M	258.17M	200M	204M	205M	187.82M	195M	192M	201M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	6.04B	5.34B	7.11B	5.95B	5.96B	5.3B	7.42B	7.82B	6.24B	5.87B	7.48B	6.2B	5.04B	4.87B	5.51B	6.64B	5.85B	4.9B	8.63B	5.25B	4.56B	5.73B
Income Tax Expense	-200.03M	305M	223M	312M	241M	336M	62M	-1M	191M	274M	-19M	257M	242M	276M	1M	233M	150M	323M	-224M	246M	-201M	258M
Shares Outstanding (Basic)	2.01B	2.01B	2.01B	2.02B	2.03B	2.04B	2.04B	2.04B	2.04B	2.03B	2.03B	2.03B	2.03B	2.02B	2.02B	2.02B	2.01B	2.01B	2B	2B	2B	2B
Shares Outstanding (Diluted)	2.03B	2.04B	2.04B	2.05B	2.06B	2.07B	2.07B	2.04B	2.06B	2.06B	2.06B	2.06B	2.05B	2.04B	2.05B	2.04B	2.03B	2.03B	2.04B	2.03B	2.02B	2.01B
EPS (Basic)	0.22	0.86	0.32	1	0.72	0.80	0.20	-0.03	0.58	0.52	0.17	0.72	0.80	0.74	0.74	5.38	0.42	0.90	0.38	0.58	0.70	0.54
EPS (Diluted)	0.22	0.86	0.31	0.98	0.70	0.78	0.20	-0.03	0.56	0.50	0.17	0.72	0.80	0.72	0.74	5.30	0.42	0.88	0.36	0.58	0.70	0.54
EBITDA	2.63B	2.77B	1.91B	3.36B	3.23B	3.09B	1.12B	1.17B	2.31B	2.07B	1.16B	2.55B	2.62B	2.75B	2.28B	2.17B	2.02B	2.72B	1.26B	2.3B	1.8B	2.08B
EBIT	2.41B	2.31B	1.12B	2.62B	2.07B	2.27B	707M	220M	1.67B	1.52B	534M	1.97B	2.17B	2.11B	1.84B	1.21B	1.1B	2.3B	890M	1.39B	1.26B	1.72B
Depreciation & Amortization	224.16M	463M	782.68M	738M	1.16B	823M	412M	951M	639M	549M	623M	579M	452M	640M	441.75M	956M	917M	418M	366M	909M	545M	361M